Fibrates: therapeutic potential for diabetic nephropathy?

European Journal of Internal Medicine
I KouroumichakisD P Mikhailidis

Abstract

Despite intensive glucose-lowering treatment and advanced therapies for cardiovascular risk factors, such as hypertension and dyslipidaemia, diabetes mellitus with its macro- and microvascular complications remains a major health problem. Especially diabetic nephropathy is a leading cause of morbidity and mortality, and its prevalence is increasing. Peroxisome proliferator-activated receptor-α (PPAR-α), a member of a large nuclear receptor superfamily, is expressed in several tissues including the kidney. Recently, experimental data have suggested that PPAR-α activation plays a pivotal role in the regulation of fatty acid oxidation, lipid metabolism, inflammatory and vascular responses, and might regulate various metabolic and intracellular signalling pathways that lead to diabetic microvascular complications. This review examines the role of PPAR-α activation in diabetic nephropathy and summarises data from experimental and clinical studies on the emerging therapeutic potential of fibrates in diabetic nephropathy.

References

Mar 1, 1991·Kidney International·F N Ziyadeh, S Goldfarb
May 1, 1995·The Journal of Clinical Investigation·G S HotamisligilB M Spiegelman
Feb 1, 1994·Kidney International·S M Mauer
Jun 1, 1994·The Journal of Clinical Investigation·G BodenL Rossetti
Nov 7, 1996·Nature·P R DevchandW Wahli
Sep 29, 1998·Metabolism: Clinical and Experimental·S M ChalkleyE W Kraegen
Oct 27, 1998·Mayo Clinic Proceedings·T O'BrienB R Zimmerman
Nov 10, 1998·Circulation·B StaelsJ C Fruchart
Jul 6, 2000·Circulation·UNKNOWN Bezafibrate Infarction Prevention (BIP) study
Oct 13, 2000·European Journal of Clinical Investigation·B Idzior-WalusG Blane
Oct 26, 2000·Current Opinion in Lipidology·A Chait, T N Wight
Jan 3, 2001·Kidney International·L F FriedB L Kasiske
Feb 7, 2001·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·A O PhillipsJ Floege
Feb 24, 2001·Current Medical Research and Opinion·H J Milionis, M S Elisaf
Jun 28, 2001·Journal of Atherosclerosis and Thrombosis·T NagaiM Mori
May 25, 2002·Kidney International·Paisit PaueksakonAgnes B Fogo
Jul 12, 2002·American Journal of Physiology. Renal Physiology·Allison A Eddy
Oct 17, 2003·Current Drug Targets. Inflammation and Allergy·A CabreroM Vázquez
Nov 11, 2003·Current Medical Research and Opinion·Vasilios G AthyrosUNKNOWN GREACE Study Collaborative Group
Jan 7, 2004·American Journal of Nephrology·Christine K Abrass
Mar 17, 2004·Current Atherosclerosis Reports·Sergio Fazio, MacRae F Linton
Apr 14, 2004·Archives of Ophthalmology·John H KempenUNKNOWN Eye Diseases Prevalence Research Group

❮ Previous
Next ❯

Citations

Oct 1, 2013·Alzheimer's Research & Therapy·Yasuko Kitagishi, Satoru Matsuda
Feb 18, 2014·The Journal of Clinical Investigation·Shenaz KhanJeffrey R Schelling
Mar 12, 2013·PPAR Research·Satoru MatsudaYasuko Kitagishi
Jun 24, 2014·Laboratory Investigation; a Journal of Technical Methods and Pathology·Bardia AskariCharles E Alpers
Sep 30, 2014·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Pitchai BalakumarSokkalingam A Dhanaraj
Dec 1, 2012·Current Opinion in Nephrology and Hypertension·Susan V McLennanStephen M Twigg
Apr 18, 2016·Metabolism: Clinical and Experimental·Amirhossein SahebkarJorge Joven
Oct 22, 2016·Archives of Physiology and Biochemistry·Nouf Mohamed Al-RasheedHala Aboulfotooh Attia
May 29, 2015·International Urology and Nephrology·M PappaK Katopodis
Feb 8, 2014·Ageing Research Reviews·Marijn M SpeeckaertJoris R Delanghe
Jun 7, 2016·Nature Reviews. Nephrology·Vivette D D'AgatiManuel Praga
Apr 13, 2017·Biochemical and Biophysical Research Communications·Wen ChenJian Han
Dec 29, 2013·Journal of Lipid Research·Michal Herman-EdelsteinUzi Gafter
Aug 6, 2017·Journal of the American Society of Nephrology : JASN·Hazel H Szeto
Dec 12, 2019·Expert Opinion on Therapeutic Patents·Ichiro Takada, Makoto Makishima
Jan 3, 2018·International Journal of Molecular Sciences·Yonghui HeLin Xi
Apr 1, 2020·Frontiers in Medicine·Hee-Seong JangBabu J Padanilam
Jan 23, 2017·Medical Science Monitor : International Medical Journal of Experimental and Clinical Research·Haiping ZhuHuaqun Chen
Jul 28, 2021·Clinical and Experimental Pharmacology & Physiology·Barbara Bruna Abreu CastroHelady Sanders-Pinheiro

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Cell Adhesion Molecules in AS

Cell adhesion molecules expressed on the vascular endothelium and circulating leukocytes in response to inflammatory stimuli are implicated in atherosclerosis. Here is the latest research.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Cardiovascular Disorder in Diabetes

Diabetes is associated with an increased risk of cardiovascular disorders and heart failure. Discover the latest research here.

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.

Related Papers

European Journal of Clinical Investigation
Michael S KostapanosMoses S Elisaf
JAMA : the Journal of the American Medical Association
Josef CoreshAndrew S Levey
Clinical Journal of the American Society of Nephrology : CJASN
Elisabeth R MathiesenPeter Damm
© 2021 Meta ULC. All rights reserved